Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Rituximab in Turkish neuromyelitis optica patients with limited response to other immunosuppressants.
Disability profile of multiple sclerosis in New Zealand.
Role of executive functions in prospective memory in multiple sclerosis: Impact of the strength of cue-action association.
Hypothesis: Fingolimod explores new horizons in treatment of lymphoma.
Trigeminal autonomic cephalalgia as a presenting feature of Neuromyelitis Optica: "A rare combination of two uncommon disorders".
Evaluation of KIR4.1 as an Immune Target in Multiple Sclerosis.
Cutting Edge: c-Kit Signaling Differentially Regulates Type 2 Innate Lymphoid Cell Accumulation and Susceptibility to Central Nervous System Demyelination in Male and Female SJL Mice.
Deletion of jun proteins in adult oligodendrocytes does not perturb cell survival, or myelin maintenance in vivo.
HDAC inhibitors mitigate ischemia-induced oligodendrocyte damage: potential roles of oligodendrogenesis, VEGF, and anti-inflammation.
5-Aminoisoquinolin-1-one (5-AIQ), a Water-Soluble Inhibitor of the Poly¬(ADP Ribose)¬Polymerases (PARPs).
Comparison of Compliance And Discontinuation Rates Among Ms Patients Treated With Fingolimod and Other Disease-Modifying Therapies: A Canadian Retrospective Claims Analysis.
TNFRSF1A in multiple sclerosis: A tale of soluble receptors and signaling cascades.
Omega-3 Fatty Acids for Depression in Multiple Sclerosis: A Randomized Pilot Study.
Identification of Vulnerable Cell Types in Major Brain Disorders Using Single Cell Transcriptomes and Expression Weighted Cell Type Enrichment.
Chronic inflammatory demyelinating polyneuropathy in common variable immunodeficiency.
Postural control, falls and fear of falling in people with multiple sclerosis without mobility aids.
Inhibin-a immunoreactivity in nervous system lesions.
A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking.
Association of CD58 Polymorphism with Multiple Sclerosis and Response to Interferon ß Therapy in A Subset of Iranian Population.
Participant recruitment into a randomised controlled trial of exercise therapy for people with multiple sclerosis.
Gray Matter Correlates of Cognitive Performance Differ between Relapsing-Remitting and Primary-Progressive Multiple Sclerosis.
The crystal structure of an integral membrane fatty acid α-hydroxylase.
Comparison of Network Meta-Analysis and Traditional Meta-Analysis for Prevention of Relapses In Multiple Sclerosis.
Friends or Foes: Matrix Metalloproteinases and Their Multifaceted Roles in Neurodegenerative Diseases.
Anxiety, depression and fatigue at 5-year review following CNS demyelination.

Pages